Age Related Macular Degeneration Market

1. Market Research Future Age Related Macular Degeneration Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Age Related Macular Degeneration Market - Scenario Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally. Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets. Request Sample copy at https://www.marketresearchfuture.com/sample_request/5736 Players Covered: The top market players in the global age-related macular degeneration market include F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG and Santen Pharmaceuticals. Hoffmann-La Roche AG currently holds around 13% share in the market. The company offers various products in the pharmaceutical, diagnostics, and research industries. Roche is the world pioneer in vitro diagnostics and tissue-based cancer diagnostics and a leader in diabetes management. In October 2016, the company got FDA approval for Lucentis 0.5 mg for the treatment of neovascular (wet) age-related macular degeneration. Segmentation: The global age-related macular degeneration is segmented based on type, stages, age group, diagnosis & treatment, route of administration, end-user and region. By type, the market is segmented into wet age-related macular degeneration (Wet AMD) and dry age-related macular degeneration (Dry AMD). Wet AMD accounts for more than 50% of the total market and is expected to grow at the highest CAGR of 7.6% during the forecast period. Wet AMD owes its rapid growth and market leading position to the fact that it is a key cause of 90% acute blindness and the rapidly growing geriatric population. By stages, the market is segmented into early-stage age-related macular degeneration, intermediate age-related macular degeneration, degeneration. The intermediate stage of AMD is one of the most common forms of AMD and as such holds the largest share of the market and is expected to grow with the fastest CAGR during the assessment period. late-stage age-related macular By age group, the market is segmented into above 75 years, above 60 years, and above 40 years. Of these, the above 75 segment is poised to grow at the fastest CAGR of 7.5% and presently holds the most significant market share. This is primarily due to the highly common nature of this disease among this age group.

2. Market Research Future By diagnosis & treatment, the market is segmented into treatment, and diagnosis, with the treatment segment accounting for the largest market share and highest CAGR. Novel treatment methods drive the growth for this segment due to the high demand for treatment of wet AMD. By route of administration, the market is segmented into intravitreal route of administration and intravenous route administration. The intravitreal route of administration is most popular and holds the largest share of the market and is expected to grow at a CAGR of 7.7% during the review period. By end-user, the market is segmented into hospital & clinics, diagnostic centers, and academic research institutes. Due to the increasing number of patients seeking treatment, hospitals and clinics hold just over half the market share. This segment is expected to proliferate as the geriatric population increases and is set to witness the fastest CAGR of 7.6%. Regional Analysis The Americas, led by the U.S, account for the most significant region across the globe. According to the report published by Centers for Disease Control and Prevention (CDC) in 2015, it was estimated that about 1.8 million people are suffering from age-related macular degenerations in America. Similarly, according to the United States Census Bureau, around 49.2 million adults aged 65 and above were present in the U.S. as of 2016. Growing government initiatives and favorable policies regarding eye-care are expected to propel the region during the forecast period. Europe, which closely follows the Americas is the second largest market due to the presence of a large geriatric population and increasing incidences of the disease. Government initiatives and an ever-improving healthcare framework combined with the demand for advanced and effective treatment drives the growth of the AMD market in the region. For instance, the Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above in 2016. The presence of prominent players and their research activities are expected to facilitate further growth during the assessment period. The emergence of many market players and the availability of abundant opportunities has made the Asia-Pacific the fastest growing region worldwide. The increasing prevalence of eye- disorders, increased healthcare spending and recognition of opportunities by international market players are driving robust growth for the region. According to the WHO, 90% of total visually impaired people live in developing countries in the Asia Pacific region. Countries such as India and China lead market growth and have a vast patient population which is creating a high demand for effective treatment options due to their rapidly growing economies. These economies are driving the demand for improved healthcare services and attracting international players for improvement of healthcare services. Browse Complete Report at https://www.marketresearchfuture.com/reports/age-related- macular-degeneration-market-5736 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),

3. Market Research Future Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com